Techbio & Biotech: Why the right connections matter

As biotech and techbio increasingly converge, choosing where to build and expand your company is becoming more than a question of market access.

In a recent interview with PharmaPhorum during the LSX Congress 2026 USA in Boston, Valentina Francia, Manager Ecosystems and Investment Promotion at Basel Area Business & Innovation highlights the growing presence of techbio companies and explains why in-person connections still remain essential for accessing scientific expertise, building partnerships and fostering collaboration, even as life sciences teams increasingly work remotely and across borders.

For companies considering Europe as their next market, establishing a local presence can help turn these connections into opportunities for growth. Europe offers established clinical research capabilities, experienced development partners and regulatory frameworks that prioritize patient safety, supporting companies from discovery through clinical development and commercialization.